News articles about Valeritas Holdings (NASDAQ:VLRX) have trended somewhat positive recently, according to Accern. The research group identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Valeritas Holdings earned a media sentiment score of 0.02 on Accern’s scale. Accern also gave media coverage about the company an impact score of 45.8652707614418 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Valeritas Holdings (NASDAQ:VLRX) traded down 3.02% on Tuesday, hitting $3.21. 11,350 shares of the stock traded hands. Valeritas Holdings has a 12-month low of $3.00 and a 12-month high of $6.25. The stock’s market cap is $21.96 million. The stock has a 50-day moving average price of $3.36 and a 200 day moving average price of $3.38.

Valeritas Holdings (NASDAQ:VLRX) last announced its earnings results on Friday, August 11th. The company reported ($1.83) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($1.87) by $0.04. The company had revenue of $4.79 million during the quarter, compared to the consensus estimate of $5.11 million. On average, equities analysts expect that Valeritas Holdings will post ($8.60) EPS for the current fiscal year.

Several brokerages have commented on VLRX. ValuEngine lowered shares of Valeritas Holdings from a “sell” rating to a “strong sell” rating in a research note on Wednesday, July 19th. Wedbush assumed coverage on shares of Valeritas Holdings in a report on Monday, July 10th. They issued an “outperform” rating and a $12.00 price objective for the company.

COPYRIGHT VIOLATION NOTICE: This piece of content was first reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this piece of content on another publication, it was stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be viewed at

About Valeritas Holdings

Valeritas, Inc is a United States-based company, which is engaged in developing and commercializing treatment solutions that contribute to clinical outcomes for patients. The Company’s portfolio includes V-Go disposable insulin delivery device, which is distributed through retail pharmacy. Its V-Go delivers insulin at a continuous preset basal rate and bolus dosing for adults with Type 2 diabetes requiring insulin.

Insider Buying and Selling by Quarter for Valeritas Holdings (NASDAQ:VLRX)

Receive News & Ratings for Valeritas Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.